Lenabasum
- Generic Name
- Lenabasum
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C25H36O4
- CAS Number
- 137945-48-3
- Unique Ingredient Identifier
- OGN7X90BT8
- Background
Ajulemic acid has been used in trials studying the treatment of Cystic Fibrosis, Dermatomyositis, and Diffuse Cutaneous Systemic Sclerosis.
- Associated Conditions
- -
- Associated Therapies
- -
JBT-101 in Systemic Lupus Erythematosus (SLE)
Phase 2
Completed
- Conditions
- Systemic Lupus ErythematosusLupusSLE
- Interventions
- Drug: JBT-101Drug: Placebo
- First Posted Date
- 2017-03-28
- Last Posted Date
- 2022-11-18
- Target Recruit Count
- 109
- Registration Number
- NCT03093402
- Locations
- 🇺🇸
Temple University, Philadelphia, Pennsylvania, United States
🇺🇸Yale University, New Haven, Connecticut, United States
🇺🇸Duke University, Durham, North Carolina, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath